Literature DB >> 22752314

The extent of cardiac myosin binding protein-C phosphorylation modulates actomyosin function in a graded manner.

Abbey E Weith1, Michael J Previs, Gregory J Hoeprich, Samantha Beck Previs, James Gulick, Jeffrey Robbins, David M Warshaw.   

Abstract

Cardiac myosin binding protein-C (cMyBP-C), a sarcomeric protein with 11 domains, C0-C10, binds to the myosin rod via its C-terminus, while its N-terminus binds regions of the myosin head and actin. These N-terminal interactions can be attenuated by phosphorylation of serines in the C1-C2 motif linker. Within the sarcomere, cMyBP-C exists in a range of phosphorylation states, which may affect its ability to regulate actomyosin motion generation. To examine the functional importance of partial phosphorylation, we bacterially expressed N-terminal fragments of cMyBP-C (domains C0-C3) with three of its phosphorylatable serines (S273, S282, and S302) mutated in combinations to either aspartic acids or alanines, mimicking phosphorylation and dephosphorylation respectively. The effect of these C0-C3 constructs on actomyosin motility was characterized in both the unloaded in vitro motility assay and in the load-clamped laser trap assay where force:velocity (F:V) relations were obtained. In the motility assay, phosphomimetic replacement (i.e. aspartic acid) reduced the slowing of actin velocity observed in the presence of C0-C3 in proportion to the total number phosphomimetic replacements. Under load, C0-C3 depressed the F:V relationship without any effect on maximal force. Phosphomimetic replacement reversed the depression of F:V by C0-C3 in a graded manner with respect to the total number of replacements. Interestingly, the effect of C0-C3 on F:V was well fitted by a model that assumed C0-C3 acts as an effective viscous load against which myosin must operate. This study suggests that increasing phosphorylation of cMyBP-C incrementally reduces its modulation of actomyosin motion generation providing a tunable mechanism to regulate cardiac function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752314      PMCID: PMC3522762          DOI: 10.1007/s10974-012-9312-y

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  55 in total

1.  Control of in vivo left ventricular [correction] contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation.

Authors:  Takahiro Nagayama; Eiki Takimoto; Sakthivel Sadayappan; James O Mudd; J G Seidman; Jeffrey Robbins; David A Kass
Journal:  Circulation       Date:  2007-11-05       Impact factor: 29.690

2.  Cardiac myosin binding protein-C modulates actomyosin binding and kinetics in the in vitro motility assay.

Authors:  Walid Saber; Kelly J Begin; David M Warshaw; Peter VanBuren
Journal:  J Mol Cell Cardiol       Date:  2008-03-29       Impact factor: 5.000

3.  Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function.

Authors:  Carl W Tong; Julian E Stelzer; Marion L Greaser; Patricia A Powers; Richard L Moss
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

4.  Ablation of cardiac myosin-binding protein-C accelerates stretch activation in murine skinned myocardium.

Authors:  Julian E Stelzer; Sandy B Dunning; Richard L Moss
Journal:  Circ Res       Date:  2006-03-30       Impact factor: 17.367

5.  Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.

Authors:  Edward P Debold; J P Schmitt; J B Patlak; S E Beck; J R Moore; J G Seidman; C Seidman; D M Warshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-09       Impact factor: 4.733

6.  Cardiac myosin-binding protein-C phosphorylation and cardiac function.

Authors:  Sakthivel Sadayappan; James Gulick; Hanna Osinska; Lisa A Martin; Harvey S Hahn; Gerald W Dorn; Raisa Klevitsky; Christine E Seidman; Jonathan G Seidman; Jeffrey Robbins
Journal:  Circ Res       Date:  2005-10-13       Impact factor: 17.367

7.  Cardiac myosin binding protein C phosphorylation is cardioprotective.

Authors:  Sakthivel Sadayappan; Hanna Osinska; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffrey D Molkentin; Christine E Seidman; Jonathan G Seidman; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.

Authors:  Adam M Jacques; O'Neal Copeland; Andrew E Messer; Clare E Gallon; Katie King; William J McKenna; Victor T Tsang; Steven B Marston
Journal:  J Mol Cell Cardiol       Date:  2008-06-04       Impact factor: 5.000

9.  Effects of the N-terminal domains of myosin binding protein-C in an in vitro motility assay: Evidence for long-lived cross-bridges.

Authors:  Maria V Razumova; Justin F Shaffer; An-Yue Tu; Galina V Flint; Michael Regnier; Samantha P Harris
Journal:  J Biol Chem       Date:  2006-10-01       Impact factor: 5.157

10.  Contribution of the myosin binding protein C motif to functional effects in permeabilized rat trabeculae.

Authors:  Maria V Razumova; Kristina L Bezold; An-Yue Tu; Michael Regnier; Samantha P Harris
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

View more
  26 in total

1.  A gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C increases binding to actin.

Authors:  Kristina L Bezold; Justin F Shaffer; Jaskiran K Khosa; Elaine R Hoye; Samantha P Harris
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

2.  The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility.

Authors:  Kenneth S Gresham; Ranganath Mamidi; Julian E Stelzer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

Review 3.  Molecular modulation of actomyosin function by cardiac myosin-binding protein C.

Authors:  Michael J Previs; Arthur J Michalek; David M Warshaw
Journal:  Pflugers Arch       Date:  2014-01-10       Impact factor: 3.657

4.  Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function.

Authors:  Michael J Previs; Ji Young Mun; Arthur J Michalek; Samantha Beck Previs; James Gulick; Jeffrey Robbins; David M Warshaw; Roger Craig
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-23       Impact factor: 11.205

Review 5.  Structure, sarcomeric organization, and thin filament binding of cardiac myosin-binding protein-C.

Authors:  Roger Craig; Kyoung Hwan Lee; Ji Young Mun; Iratxe Torre; Pradeep K Luther
Journal:  Pflugers Arch       Date:  2014-01-11       Impact factor: 3.657

Review 6.  Earning stripes: myosin binding protein-C interactions with actin.

Authors:  Sabine J van Dijk; Kristina L Bezold; Samantha P Harris
Journal:  Pflugers Arch       Date:  2014-01-19       Impact factor: 3.657

Review 7.  Diatrack particle tracking software: Review of applications and performance evaluation.

Authors:  Pascal Vallotton; Antoine M van Oijen; Cynthia B Whitchurch; Vladimir Gelfand; Leslie Yeo; Georgios Tsiavaliaris; Stephanie Heinrich; Elisa Dultz; Karsten Weis; David Grünwald
Journal:  Traffic       Date:  2017-10-23       Impact factor: 6.215

8.  Functional dissection of myosin binding protein C phosphorylation.

Authors:  Manish K Gupta; James Gulick; Jeanne James; Hanna Osinska; John N Lorenz; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2013-08-31       Impact factor: 5.000

9.  The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.

Authors:  Ji Young Mun; Robert W Kensler; Samantha P Harris; Roger Craig
Journal:  J Mol Cell Cardiol       Date:  2015-12-21       Impact factor: 5.000

10.  N-terminal extension in cardiac myosin-binding protein C regulates myofilament binding.

Authors:  Thomas A Bunch; Victoria C Lepak; Rhye-Samuel Kanassatega; Brett A Colson
Journal:  J Mol Cell Cardiol       Date:  2018-10-22       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.